HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
JNJ
Johnson & Johnson
Healthcare Drug Manufacturers - General · New Jersey, USA · Reports in usd
Market Cap: $619.30B
Market Cap
$619.30B
Enterprise Val
$652.23B
P/E Ratio
29.43
P/B Ratio
7.63
Trailing PEG (1Y)
-0.56
As Of
Jul 9, 2026

Overview & Key Metrics

Reporting period: Mar 29, 2026 · Q1 2026
Book Value$81.19B
Gross Margin66.31%
Profit Margin66.31%
Return on Equity26.26%
Return on Assets10.70%
Current Ratio1.03
Debt/Equity0.68
LT Debt/Equity0.46
Revenue Per Share9.98

Income Statement

Mar 29, 2026
Revenue$24.06B
Cost of Revenue$8.11B
Gross Profit$15.96B
R&D$3.53B
SG&A$6.03B
Operating Expenses$9.63B
Operating Income$6.33B
Interest Expense$272.0M
Tax Expense$755.0M
Net Income$5.24B
EPS (Basic)$2.17
EPS (Diluted)$2.14
EBIT$6.26B
EBITDA$8.27B
Consolidated Income$5.24B
Non-Controlling Interests$0.00

Balance Sheet

Mar 29, 2026
Cash & Equivalents$21.69B
Accounts Receivable$17.72B
Inventory$14.58B
Current Assets$59.17B
LT Investments$0.00
Property, Plant & Equipment$23.27B
Intangibles$97.62B
Non-Current Assets$141.72B
Total Assets$200.89B
Accounts Payable$10.46B
Current Debt$17.46B
Current Liabilities$57.72B
LT Debt$37.53B
Non-Current Liabilities$61.99B
Total Liabilities$119.71B
Total Debt$54.99B
Retained Earnings$169.16B
Shareholder Equity$81.19B
Shares Outstanding2,409,898,936

Cash Flow Statement

Mar 29, 2026
Operating Cash Flow$2.51B
Investing Cash Flow-$1.04B
Financing Cash Flow$530.0M
CapEx-$1.05B
Free Cash Flow$1.47B
Depreciation & Amort.$2.00B
Stock-Based Comp$300.0M
Acquisitions / Disposals$29.0M
Investment Activity$34.0M
Debt Issued/Repaid$7.11B
Equity Issued/Repaid-$2.86B
Dividends Paid-$3.13B
Net Change in Cash$1.98B
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h